BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 28676490)

  • 1. TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α.
    Hamidi A; Song J; Thakur N; Itoh S; Marcusson A; Bergh A; Heldin CH; Landström M
    Sci Signal; 2017 Jul; 10(486):. PubMed ID: 28676490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.
    Sorrentino A; Thakur N; Grimsby S; Marcusson A; von Bulow V; Schuster N; Zhang S; Heldin CH; Landström M
    Nat Cell Biol; 2008 Oct; 10(10):1199-207. PubMed ID: 18758450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAF6 stimulates the tumor-promoting effects of TGFβ type I receptor through polyubiquitination and activation of presenilin 1.
    Gudey SK; Sundar R; Mu Y; Wallenius A; Zang G; Bergh A; Heldin CH; Landström M
    Sci Signal; 2014 Jan; 7(307):ra2. PubMed ID: 24399296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor.
    Zhang L; Zhou F; Drabsch Y; Gao R; Snaar-Jagalska BE; Mickanin C; Huang H; Sheppard KA; Porter JA; Lu CX; ten Dijke P
    Nat Cell Biol; 2012 Jun; 14(7):717-26. PubMed ID: 22706160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APPL proteins promote TGFβ-induced nuclear transport of the TGFβ type I receptor intracellular domain.
    Song J; Mu Y; Li C; Bergh A; Miaczynska M; Heldin CH; Landström M
    Oncotarget; 2016 Jan; 7(1):279-92. PubMed ID: 26583432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RanBPM interacts with TβRI, TRAF6 and curbs TGF induced nuclear accumulation of TβRI.
    Zhang J; Ma W; Tian S; Fan Z; Ma X; Yang X; Zhao Q; Tan K; Chen H; Chen D; Huang BR
    Cell Signal; 2014 Jan; 26(1):162-72. PubMed ID: 24103590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β-induced phosphorylation of Akt and Foxo transcription factors negatively regulates induced regulatory T cell differentiation.
    Kurebayashi Y; Baba Y; Minowa A; Nadya NA; Azuma M; Yoshimura A; Koyasu S; Nagai S
    Biochem Biophys Res Commun; 2016 Nov; 480(1):114-119. PubMed ID: 27697523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAF6 interacts with and ubiquitinates PIK3CA to enhance PI3K activation.
    Wang Z; Liu Y; Huang S; Fang M
    FEBS Lett; 2018 Jun; 592(11):1882-1892. PubMed ID: 29729098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes.
    Xavier S; Niranjan T; Krick S; Zhang T; Ju W; Shaw AS; Schiffer M; Böttinger EP
    J Am Soc Nephrol; 2009 Oct; 20(10):2127-37. PubMed ID: 19679673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor β induces bone marrow mesenchymal stem cell migration via noncanonical signals and N-cadherin.
    Dubon MJ; Yu J; Choi S; Park KS
    J Cell Physiol; 2018 Jan; 233(1):201-213. PubMed ID: 28213973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF6 promotes TGFβ-induced invasion and cell-cycle regulation via Lys63-linked polyubiquitination of Lys178 in TGFβ type I receptor.
    Sundar R; Gudey SK; Heldin CH; Landström M
    Cell Cycle; 2015; 14(4):554-65. PubMed ID: 25622187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus.
    Olieslagers S; Pardali E; Tchaikovski V; ten Dijke P; Waltenberger J
    Cardiovasc Res; 2011 Aug; 91(3):510-8. PubMed ID: 21478266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85α regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain.
    Hofmann BT; Jücker M
    Cell Signal; 2012 Oct; 24(10):1950-4. PubMed ID: 22735814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis.
    Zhang L; Zhou F; García de Vinuesa A; de Kruijf EM; Mesker WE; Hui L; Drabsch Y; Li Y; Bauer A; Rousseau A; Sheppard KA; Mickanin C; Kuppen PJ; Lu CX; Ten Dijke P
    Mol Cell; 2013 Sep; 51(5):559-72. PubMed ID: 23973329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation.
    Song K; Wang H; Krebs TL; Danielpour D
    EMBO J; 2006 Jan; 25(1):58-69. PubMed ID: 16362038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway.
    Bian Y; Terse A; Du J; Hall B; Molinolo A; Zhang P; Chen W; Flanders KC; Gutkind JS; Wakefield LM; Kulkarni AB
    Cancer Res; 2009 Jul; 69(14):5918-26. PubMed ID: 19584284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway.
    Vo BT; Morton D; Komaragiri S; Millena AC; Leath C; Khan SA
    Endocrinology; 2013 May; 154(5):1768-79. PubMed ID: 23515290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta.
    Yamashita M; Fatyol K; Jin C; Wang X; Liu Z; Zhang YE
    Mol Cell; 2008 Sep; 31(6):918-24. PubMed ID: 18922473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner.
    Wygrecka M; Zakrzewicz D; Taborski B; Didiasova M; Kwapiszewska G; Preissner KT; Markart P
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):614-27. PubMed ID: 22771387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway.
    Bailey JP; Nieport KM; Herbst MP; Srivastava S; Serra RA; Horseman ND
    Mol Endocrinol; 2004 May; 18(5):1171-84. PubMed ID: 14963111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.